CMRA - Comera Life Sciences Holdings, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
633.102
633.102
319.832
442.919
Cost of revenue
210.39
210.39
161.008
104.407
Gross profit
422.712
422.712
158.824
338.512
Operating expenses
Research development
1,740
1,740
1,753
1,262
Selling general and administrative
10,653
10,653
3,942
1,204
Total operating expenses
12,393
12,393
5,694
2,466
Operating income or loss
-11,970
-11,970
-5,536
-2,128
Interest expense
20.391
20.391
-
-
Total other income/expenses net
-6,014
-6,014
83.85
2.033
Income before tax
-18,004
-18,004
-5,452
-2,125
Income from continuing operations
-18,004
-18,004
-5,452
-2,125
Net income
-18,004
-18,004
-5,452
-2,125
Net income available to common shareholders
-18,378
-18,378
-5,452
-2,125
Basic EPS
-
-1.76
-0.29
-0.11
Diluted EPS
-
-1.76
-0.29
-0.11
Basic average shares
-
10,453
19,087
19,087
Diluted average shares
-
10,453
19,087
19,087
EBITDA
-
-17,890
-5,449
-2,038